A pharmacist based in the East Midlands of England plans to run 150 kilometres during the Muslim holy month of Ramadan to raise funds for an international
food charity.
Shahid Akhtar from Rainworth, Nottinghamshire started running five kilometres each day from March 23 "from about an hour before sunset and the time I can break my
fast."
So far, the 50-year-old locum pharmacist who used "to own and run a community pharmacy not so long ago", has managed to run 55 kilometres and has already raised a
total of £2,173 for the cause.
By the end of Ramadan, Shahid aims to exceed his personal target of raising £2,500 to help feed children around the world. He says the money raised through him will
go towards providing school meals for children and young people in neglected communities around the world through Charity Right.
Shahid will run everyday without consuming any food or water before, during, or immediately after the race. Having never run whilst fasting before, he thinks this
will be an "interesting new experience" for him.
The NHS Confederation has urged the government to reconsider its 'living with Covid' plan and introduce mitigating actions that will help avoid further
critical incidents being declared at the NHS front-line.
The organisation said the high rates of Covid is having a major impact on the delivery of health services and slowing down efforts to reduce large waiting lists,
noting that the country has been in the grip of another spike in Covid cases resulting from the Omicron BA.2 variant.
With more than 20,000 patients now in hospital with Covid (or who have Covid but are in hospital for other reasons) and high staff absences, NHS is facing huge
operational challenges, harming efforts to reduce waiting times in other areas, it said.
The pharmacy chain has already announced plans to permanently close hundreds of its branches across the UK to consolidate its portfolio of 2,200 stores to 1,900.
Two of its branches in North Wales will be closed next year, with its site in Rhos on Sea set to close its doors in March 2024 and the shop in Colywn Bay the
following month.
In a statement obtained by The Sun, Clwyd West MP David Jones has branded the closures "hugely bad news for the local community".
He added that it is not "a case of simple shop closures," but "another body blow for the local retail economy."
The Station Road shopping centre, where the Colwyn Bay store is located, has already seen the closure of several other prominent stores, including WHSmith, the MP
stated.
The closure of two Boots stores will leave many people "extremely worried as to how they will be able to obtain essential medicines," he added.
The Health and Social Care Committee (HSCC) has undertaken an inquiry into prevention and has published its first report of the series which focuses on
vaccination.
It has announced ten workstreams that will form the basis of inquiry, of which vaccination is one.
HSCC said: "The UK has long been one of the world leaders on vaccination - one of the most successful and cost-effective preventative tools available. However,
if challenges around uptake and bureaucratic processes in clinical trial set-up are not addressed, there is a very real risk that the UK's position as a global
leader could be lost. This cannot be allowed to happen and in this report we set out some of the steps that we think will make a difference."
It recommended a more flexible delivery model making use of a wider range of healthcare professionals.
"The NHSE vaccination and immunisation strategy must have a strong focus on tackling practical challenges that limit vaccination access, make best use of a wider
array of professionals, empower local leaders to pursue ways of addressing uptake in their own areas, and to set out guidance and examples of best practice around
how voices other than NHSE can communicate important messaging around vaccination programmes," it suggested.
The Royal Pharmaceutical Society (RPS), professional membership body for pharmacists and pharmacy, has published its manifesto for the general election,
highlighting key issues facing the next government after the election on July 4.
Local candidates are urged to recognise and support the vital role pharmacists play in supporting people's health.
The RPS teams are gearing up to influence government policy in various crucial areas. Their key asks include:
Ensuring Secure Patient Access to Medicines
Supporting a Better-Connected NHS
Enhancing Accessible Prescribing in Local Communities
Maximizing Health Improvement through Locally Accessible Pharmacy Teams
Supporting the Workforce to Deliver Patient Care
Unlocking the Potential of New Advances in Medicines
Supporting the UK's Global Position in Science and Research
Acknowledging the efforts of pharmacists and their teams, Professor Claire Anderson, President of the RPS, noted that they are "working incredibly hard to
maintain patient access to care amid workforce challenges, medicines shortages and financial pressures."
Professor Sir Jonathan Van-Tam has announced that he will step down as deputy chief medical officer (DCMO) for England at the end of March to take up a new role at the University of Nottingham.
He joined Department of Health and Social Care (DHSC) on secondment from the university in 2017, and will soon return to be the pro-vice-chancellor for Faculty of
Medicine and Health Sciences.
Professor Van-Tam said: "My time as DCMO have been the most challenging of my professional career, especially the Covid response. We all wish Covid had never happened.
Notwithstanding, it has been the greatest privilege of my professional career to have served the people of the UK during this time.
"I want to pay tribute to Professor Chris Whitty, the CMO team, my fellow scientists, public health professionals and clinicians whose support, wisdom and energy has been inspiring.
"I will continue to work until the end of March and look forward to the next challenge."
As the DCMO for Health Protection, he has played key roles in various incidents, including domestic outbreaks of MERS and monkeypox, 2017 to 2018 influenza season
and during the Covid-19 pandemic.
During the coronavirus pandemic many people found themselves working from home, and this has continued to some extent in many businesses. A change in working
environment can bring challenges, one of which can be joint pain and discomfort.
Imagine you have gone from a busy office environment, meeting in boardrooms and visiting the canteen for a coffee, to working at home on your dining room table,
walking several feet to get a cup of tea and sitting back down again, this change in surroundings can have an impact on your joints.
Community pharmacists can be a source of knowledge to help individuals that may be suffering from joint complaints, this may be from the above scenario or just
general aches and pains that come from an office based role.
Firstly, it's important for us to know the effects of sitting down at a desk all day (not a scenario I'm sure many community pharmacists experience daily):
Back pain - is one of the most common complaints. This can be caused by bad posture while sitting too high, too low, or hunched over. While this may present as
just a soreness or discomfort, if not rectified and/or accessed this can lead to some serious health issues such as spinal compression, sciatica or spinal stenosis.
Health Education England (HEE) has developed funded training offers for community pharmacists, including locums aiming to become independent prescribers.
Almost 3000 independent prescribing training places will be available to pharmacists from March 2023.
This training enables pharmacists to support patients from diagnosis to prescribing, and to provide advice and follow-up - while also helping them to feel confident
and prepared for the new challenges of their role.
Courses will be available between April 2023 and March 2024, with several universities offering multiple dates for cohort intakes. Start dates will depend on the
university provider.
Training will enable the provision of new models of care: supporting patients from diagnosis to prescribing, providing advice and follow-up, and preparing pharmacists
to provide clinical care, as pharmacy services become more widespread within emerging clinical pathways.
he British Generic Manufacturers Association (BGMA) has voted Pete Kelly, managing director of Accord UK, to become its new chair.
He replaces Peter Ballard, who has completed his second tenure as the association's chair and will now serve a further year as vice-chair.
Pete leads the UK operations of Accord, one of the largest generic and biosimilar manufacturers in Europe. In the UK, the company currently supplies a fifth of
all generic medicines.
Mark Samuels, chief executive of BGMA, said: "We are very fortunate to have someone of Pete's experience and leadership qualities to take on the mantle of chair
of the association. The industry faces a challenging period on many fronts, and Pete's input will be invaluable.
"I would also like to record my enormous gratitude to Peter Ballard, our out-going Chair who has been an incredible servant to the association over many, many years.
He will continue for another year as vice-chair, and we are pleased to have his continuing advice."
The Pharmacists' Defence Association (PDA) is playing a vital role in helping pharmacists who are dealing with stress at the workplace. It launched its new
awareness factsheet 'It's Time to Address Stress' last week.
The factsheet looks at the causes and symptoms of stress in the workplace and provides advice on ways pharmacists can access support and improve working conditions.
The association said that it recognises the well-being services offered by employers and specialist charities such as the PDA's charity partner Pharmacist Support
play an important part in helping pharmacists who may be experiencing stress.
However, the PDA is also committed to working with members to challenge employers to provide well workplaces and to help them to make real impact changes. This can
be done by addressing the causes of stress and fulfilling their responsibilities to their employees.
It added: "Under the management of Health and Safety at Work Regulations 1999, employers are required by law to protect employees from harm. Their legal obligations include identifying hazards and risks and implementing ways to reduce or eliminate them. The PDA's new factsheet highlights the importance of employers recognising the hazards causing stress as the health and safety issues they are."
The Department of Health and Social Care (DHSC) published a notification regarding the shortage of Guanfacine 2mg and 3mg modified-release tablets has
raised concerns within the healthcare community.
This critical medicine supply notification, issued on March 28th, projects the unavailability of these tablets until the week commencing May 6, 2024.
Guanfacine tablets, commonly prescribed to alleviate symptoms of hyperactivity and impulsivity while enhancing attention and concentration, play a vital role in
managing conditions like attention deficit hyperactivity disorder (ADHD).
However, the scarcity of these specific strengths poses challenges for patients reliant on this medication.
Last year, several countries across the globe experienced shortages of medications for the treatment of attention deficit hyperactivity disorder (ADHD)including
the UK, the US and Australia.
Community Pharmacy England (CPE) has cautioned that while alternative strengths of Guanfacine remain accessible, they may not adequately meet the heightened demand,
potentially resulting in treatment interruptions for patients.
A new legislation has been introduced to allow authorised pharmacists along with other healthcare professionals in Northern Ireland to certify 'fit notes',
health minister Robin Swann has announced.
Pharmacists and some other healthcare professionals in England, Scotland and Wales are already allowed to sign 'fit notes'.
Swann announced that 'fit notes' were also set to go fully digital in the future, meaning they would no longer need to be signed in ink.
He said: "I am delighted to introduce this legislation in Northern Ireland. This change will make it easier for people and employers to get the advice they need so
people can stay in work and will help free up doctors' time.
"Too often we see people being faced with unnecessary challenges to get a fit note. More professionals being able to offer this vital service will speed up the
process and support people to return to or remain in work."
A group of drugs commonly used to treat erectile dysfunction may be able to boost the effect of chemotherapy in oesophageal cancer, according to new research
funded by Cancer Research UK and the Medical Research Council.
The research, published on Tuesday (June 22) in Cell Reports Medicine, found that the drugs, known as PDE5 inhibitors can reverse chemotherapy resistance by
targeting cells called cancer-associated fibroblasts (CAFs) residing in the area surrounding the tumour.
Although this is early discovery research, PDE5 inhibitors combined with chemotherapy, may be able to shrink some oesophageal tumours more than chemotherapy could
alone, tackling chemotherapy resistance, which is one of the major challenges in treating oesophageal cancer.
Oesophageal cancer affects the food pipe that connects the mouth to the stomach, and while it is a relatively rare cancer, the UK has one of the higher rates in the
world, with 9,300 new oesophageal cancer cases in the UK every year.
Resistance to chemotherapy in oesophageal cancer is influenced by the tumour microenvironment, the area that sounds the tumour. This is made up of molecules, blood
vessels, and cells such as cancer associated fibroblasts (CAFs), which are important for tumour growth. It feeds the tumour and can act as a protective cloak,
preventing treatments like chemotherapy from having an effect.
With the Labour Party now in power, there is keen interest in the healthcare initiatives they pledged during their election campaign and how these proposals
will shape the future of NHS.
One of the key pledges in their healthcare reform is the introduction of the Community Pharmacist Prescribing Service, which aims to empower pharmacists with
independent prescribing rights where clinically suitable.
While pharmacists appreciated Labour's acknowledgment of their role in patient care through expanded prescribing rights, they foresee some challenges in
implementing the service.
"Budgets will be a key issue," said Pharmacist Thorrun Govind, also a Healthcare Lawyer (Brabners LLP).
However, she noted that, given the success of pharmacist prescribing services in the devolved nations, there is "a road map in place."
The latest findings from the National Cancer Patient Experience Survey 2022 by QualityWatch, a joint programme with the Nuffield Trust and the Health
Foundation shed light on concerning disparities faced by ethnic minority communities in the UK healthcare system.
Despite strides in cancer care, the survey highlights persistent challenges in easy and equitable access to timely diagnosis and quality communication,
particularly for individuals from Mixed, Black, or Asian backgrounds.
Key insights from the survey underscored that individuals from ethnic minority groups often require a higher number of interactions with healthcare professionals
before receiving a cancer diagnosis.
Notably, one in three people from Mixed, Black, or Asian ethnicities needed three or more visits to a GP practice, compared to the average of one in five across
the population.
These delays in diagnosis can have significant implications for treatment outcomes and overall patient experience.
Moreover, the survey revealed concerning trends regarding the quality of communication following a cancer diagnosis among ethnic minority patients.
In a rapidly evolving and competitive landscape, the pharmaceutical industry faces unique challenges when it comes to marketing its products and services.
With stringent regulations, complex target audiences, and a need for trust and credibility, pharma companies need to employ effective marketing strategies to stand
out in the crowd. In this blog article, we will explore some key marketing strategies for the pharma industry that can help boost their visibility, engage their
target audience, and drive business growth.
UNDERSTANDING THE UNIQUE LANDSCAPE
The pharma industry operates in a highly regulated environment, where compliance and ethical considerations play a crucial role. Before diving into marketing
strategies, it is essential to have a deep understanding of the industry's dynamics and the target audience. Researching the market, identifying patient needs,
and studying the competitive landscape are vital steps in developing an effective marketing plan.
EMBRACING DIGITAL TRANSFORMATION
Digital transformation has revolutionized marketing across industries, and the pharma sector is no exception. Embracing digital channels and technologies can
significantly enhance the reach and impact of marketing efforts. Pharma companies can leverage social media platforms, create engaging content, and build online
communities to connect with patients, healthcare professionals, and other stakeholders. Implementing robust digital marketing strategies allows for personalized
messaging, real-time communication, and targeted campaigns that resonate with the target audience.
If you have recently been diagnosed with hearing loss, you may be feeling overwhelmed and unsure of what to do next. You are not alone - millions of people
around the world are living with hearing loss. The good news is that there are many resources available to help you learn how to manage your condition and live a
full life. In this blog post, we will discuss some of the most common issues that people with hearing loss face and provide tips on how to handle them.
HANDLING ISSUES FROM HEARING LOSS - HOW TO DO IT PROPERLY
Hearing loss is certainly a difficult obstacle to face in life, but it doesn't have to stop you from living a full and rich life. Of course, hearing loss comes with
its own set of unique challenges, but there are ways to manage them. From learning what hearing aids are the best for you to communicate with loved ones, to the
different types of therapies available, we're here to help you find the answers you need. Generally speaking, there are four main issues that people with hearing
loss face; Isolation, communication difficulties, feeling overwhelmed and frustrated, and depression. Unfortunately, each of these "consequences" will likely get
worse if hearing loss is not managed early on. Here are some tips on how to handle each one:
Whether it's the effects of the coronavirus pandemic and those suffering with long Covid, or the financial pressures of rising living costs, these hard times
can affect absolutely anyone's mental health.
Mental health problems have worsened across all age-groups in the last few years, from lack of social interaction, unexpected bereavements or the significant impact
of a physical injury or long-term illness taking its toll on mental wellbeing - these challenging experiences and situations that we face throughout life leave a
big strain on the population.
Ultimately, there is an urgent need to reduce rising levels of mental ill-health in our society. As a pharmacist with 25 years' experience in healthcare, I feel I
have an obligation to my patients to support them with their healthcare needs, and mental health should be treated just the same as physical health.
Despite efforts to improve NHS mental health services, patients may still not be receiving the appropriate immediate care as they are often provided with online
counselling or an App for long-term support (online support introduced since the pandemic).
Community pharmacists are in a unique position to be advocates for patients with mental illness as they are the healthcare professionals' patients see most often.
This is a good opportunity for pharmacists to speak to patients face-to-face and give them advice in a more practical way rather than potentially waiting weeks for
an GP appointment.
The British Generic Manufacturers Association (BGMA) on Monday alerted the Health and Social Care Committee that medicines shortages have increased and
are "around double what they were a year ago."
BGMA chief executive Mark Samuels told the committee that they have been highlighting the medicine shortage risk to ministers since July 2021 and the association
is "very concerned" about the current situation.
"We've been monitoring it for several years now, and as you saw in the written evidence, shortages have increased. They're around double what they were a year ago.
We have them at 101 shortages in February this year," said Samuels.
Dr Rick Greville, director of distribution and supply at the Association of the British Pharmaceutical Industry (ABPI), highlighted that the problem of drug
shortages in the UK is a "long-standing issue" and the scarcity of certain medications "continues to be challenging".
NHS West Yorkshire Integrated Care Board (ICB)'s decision to withdraw gluten free prescriptions for people with coeliac disease across Leeds and Calderdale
has disappointed Coeliac UK.
In a statement released on Thursday, the charity, which provides support and advice to those living with the disease, has raised "grave concerns" about the decision,
warning that it will have a detrimental impact on the coeliac community.
The policy is currently implemented across the ICB's other places including Bradford district and Craven, Kirklees and Wakefield district, preventing coeliac
patients from accessing gluten free bread and flour mix on prescription.
NHS West Yorkshire ICB wants to align its gluten free prescribing guidelines across its five places.
But the charity is worried that the additional cost of gluten free staple products will poses a real challenge to maintaining the gluten-free diet, which is the
only treatment for the condition.